PGEN
PRECIGEN, INC.
PRECIGEN, INC. (PGEN) has 13 SEC Form 4 filings (16 transaction rows) in the rolling window, disclosed by 5 distinct insiders. Most recent filing: Jul 1, 2026.
The most active filer is Chief Financial Officer Thomasian Harry Jr. with 3 filings. Insiders have net sold $4.6M over the trailing 6 months.
- Industry:Biotechnology
- CEO:Helen Sabzevari
- Employees:143
- HQ:Germantown, MD, US
- IPO:2013-08-08
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$4.6M
reported sales (SEC code S)
Unique Insiders
5
in the rolling window
Market Cap
$2.0B
latest known value
| Source | ||||||
|---|---|---|---|---|---|---|
| Chief Financial Officer | Sale | 28,571 | $165K | Jul 1 | SEC ↗ | |
| Chief Financial Officer | Sale | 171,429 | $948K | Jul 1 | SEC ↗ | |
| President and CEO | Sale | 346,836 | $2.0M | Jul 1 | SEC ↗ | |
| Chief Operating Officer | Sale | 42,924 | $251K | Jul 1 | SEC ↗ | |
Lehr Donald P.First filing | Chief Legal Officer | Sale | 29,131 | $127K | Jun 1 | SEC ↗ |
Tennant PhilFirst filing | Chief Commercial Officer | Sale | 30,272 | $132K | Jun 1 | SEC ↗ |
Thomasian Harry Jr.First filing | Chief Financial Officer | Sale | 41,884 | $183K | Jun 1 | SEC ↗ |
Sabzevari HelenFirst filing | President and CEO | Sale | 119,250 | $520K | Jun 1 | SEC ↗ |
Shah Rutul RFirst filing | Chief Operating Officer | Sale | 42,703 | $186K | Jun 1 | SEC ↗ |
Related companies
PRECIGEN, INC. is in the Healthcare sector.